KYTX
Kyverna Therapeutics, Inc.
6.20$
+0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
Kyverna Therapeutics, Inc. (KYTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -40 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -19 | -26 | -24 | -27 | -37 | -45 | -32 | -43 | -34 | -42 | -40 | -159 | |
| 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 1.6 | |
| 0.5 | 0.8 | 2.3 | 1.3 | 3.4 | 1.4 | 2.2 | 2.5 | 2.7 | 2.7 | 3.2 | 3.5 | 12 | |
| 3.4 | 1.0 | -1.8 | 4.4 | 5.3 | 0.0 | -2.2 | 8.2 | -8.9 | 1.7 | -5.4 | 0.1 | -12 | |
| 0.3 | 0.3 | 0.5 | 1.0 | 0.1 | 0.5 | 0.0 | 0.2 | 0.4 | 0.0 | 0.0 | 0.3 | 0.7 | |
| -54 | 32 | -123 | -68 | 0.7 | 29 | 5.6 | 29 | 23 | -17 | -50 | 36 | -8.8 | |
| – | – | – | – | -0.2 | -0.2 | -0.3 | -0.3 | -0.1 | -0.1 | -0.1 | -0.1 | -0.4 | |
| 35 | -1.4 | 338 | -0.6 | -0.2 | -0.2 | -0.4 | -0.6 | 1.5 | 141 | -0.1 | 3.8 | 146 | |
| -30 | 12 | 190 | -93 | -27 | -8.0 | -40 | -3.4 | -19 | 90 | -92 | -0.4 | -22 | |
| -11 | -19 | -26 | -25 | -28 | -38 | -45 | -32 | -44 | -34 | -42 | -41 | -159 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.